氮卓斯汀鼻喷剂联合地氯雷他定治疗变应性鼻炎疗效的Meta分析

doi:10.3969/j.issn.1006-7795.2018.03.027

摘要/Abstract

摘要： 目的应用Meta分析的方法分析氮卓斯汀鼻喷剂联合地氯雷他定治疗变应性鼻炎的疗效。方法检索的数据库：中文数据库包括CNKI、万方、VIP、CBM等，英文数据库包括PubMed、Embase、Medline、Cochrane等。制定综合检索式，选用纽卡斯尔-渥太华量表（Newcastle-Ottawa Scale，NOS）进行质量评估，使用RevMan5.3软件对本次研究的数据进行处理，统计学效应指标选用RR值和95% CI，I²和P值为异质性检验的指标，然后进行敏感性分析、亚组分析、发表偏倚评估。其中发表偏倚评估使用Egger's法，如有必要使用剪补法进一步分析。结果氮卓斯汀鼻喷剂联合地氯雷他定组与氮卓斯汀鼻喷剂组比较，Z=8.18（P<0.000 01）、RR（95% CI）：1.21（1.16，1.27），差异有统计学意义（P<0.05）。亚组分析显示A组，Z=5.62（P<0.000 01）、RR（95% CI）：1.18（1.12，1.26），差异有统计学意义（P<0.05）。B组Z=3.62（P=0.000 3）、RR（95% CI）：1.19（1.08，1.31），差异有统计学意义（P<0.05）。C组Z=4.91（P<0.000 01）、RR（95% CI）：1.33（1.19，1.50），差异有统计学意义（P<0.05）。敏感性分析示Z=6.27（P<0.000 01）、RR（95% CI）：1.19（1.13，1.26），差异有统计学意义（P<0.05）。结论氮卓斯汀鼻喷剂联合地氯雷他定比单一使用氮卓斯汀鼻喷剂治疗变应性鼻炎有更好的疗效。

关键词: 氮卓斯汀鼻喷剂, 地氯雷他定, 变应性鼻炎, Meta分析

Abstract: Objective To analyze therapeutic effect of azelastine nasal spray combined with desloratadine in the treatment of allergic rhinitis by Meta analysis.Methods Retrieved database:Chinese database includes CNKI, Wan Fang, VIP, CBM, etc. The English database includes PubMed, Embase, MEDLINE, Cochrane and so on. The quality evaluation was made by the Newcastle Ottawa Scale (NOS). Useing RevMan5.3 software to process data. The statistical effect index was selected by risk ratio (RR) value and 95%CI, I² and P values were selected as indicators of heterogeneity test, and sensitivity analysis, subgroup analysis were carried out. And conduct publication bias assessment. Publication bias was assessed by the Egger's method, if necessary further analysis will be made. Result Compared with azelastine nasal spray combined with desloratadine group and azelastine nasal spray group in the treatment of allergic rhinitis, Z=8.18(P<0.000 01), RR(95% CI):1.21(1.16,1.27) and the difference was statistically significant (P<0.05). Subgroup analysis showed that A group Z=5.62(P<0.000 01) and RR(95% CI):1.18(1.12, 1.26), and the difference was statistically significant (P<0.05). B Group Z=3.62(P=0.000 3) and RR(95% CI):1.19 (1.08, 1.31), the difference was statistically significant (P<0.05). C group Z=4.91(P<0.000 01), RR(95% CI):1.33(1.19, 1.50), the difference was statistically significant (P<0.05). Sensitivity analysis showed that Z=6.27(P<0.000 01), RR(95% CI):1.19(1.13, 1.26), the difference was still statistically significant (P<0.05).Conclusion Azelastine nasal spray combined with desloratadine is better than Azelastine nasal spray in the treatment of allergic rhinitis.

Key words: azelastine nasal spray, desloratadine, allergic rhinitis, Meta-analysis

中图分类号:

R765.21

高占梅, 宋扬, 刘华, 文昌隆, 孙海洋. 氮卓斯汀鼻喷剂联合地氯雷他定治疗变应性鼻炎疗效的Meta分析[J]. 首都医科大学学报, 2018, 39(3): 458-464.

Gao Zhanmei, Song Yang, Liu Hua, Wen Changlong, Sun Haiyang. Rapeutic effect of azelastine nasal spray combined with desloratadine in the treatment of allergic rhinitis: a system review and Meta-analysis[J]. Journal of Capital Medical University, 2018, 39(3): 458-464.

参考文献

[1] Wallace D V, Dykewicz M S, Oppenheimer J, et al. Pharmacologic treatment of seasonal allergic rhinitis:synopsis of guidance from the 2017 joint task force on practice parameters.[J]. Ann Int Med, 2017, 167(12):876-881.
[2] Eifan A O, Orban N T, Jacobson M R, et al. Severe persistent allergic rhinitis:inflammation but no histologic features of structural upper airway remodeling.[J]. Am J Resp Crit Care Med, 2015, 192(12):1431-1439.
[3] Pacharra M, Kleinbeck S, Schäper M, et al. Does seasonal allergic rhinitis increase sensitivity to ammonia exposure?[J]. Int J Hyg Environ Health, 2017, 220(5):840-848.
[4] 罗杰,冷卫东.系统评价/Meta分析理论与实践[M].北京:军事医学科学出版社,2013:81-82.
[5] Higgins J P T, Green S. Cochrane handbook for systematic reviews of interventions version 5. 1. 0[EB/OL].(2018-02-27). http://handbook.cochrane.org/.
[6] 凌云, 杨春悦, 杨红梅. 氮卓斯汀鼻喷剂联合地氯雷他定治疗过敏性鼻炎65例的疗效评价[J]. 中国免疫学杂志, 2014, 30(6):828-830.
[7] 熊义豪, 刘琳. 氮卓斯汀鼻喷剂联合地氯雷他定治疗变应性鼻炎105例疗效观察[J]. 现代诊断与治疗, 2014, 25(19):4425-4426.
[8] 欧阳绍基, 姚榕威, 徐学江,等. 氮卓斯汀鼻喷剂联合地氯雷他定治疗过敏性鼻炎的随机对照研究[J]. 中国医学创新, 2015, 12(21):1-4.
[9] 王明婧. 盐酸氮卓斯汀鼻喷剂联合地氯雷他定治疗过敏性鼻炎40例[J]. 中国药业, 2015, 24(17):88-90.
[10] 张志明. 盐酸氮卓斯汀鼻喷剂联合地氯雷他定治疗过敏性鼻炎的临床疗效[J]. 中外医学研究, 2015, 13(17):149-150.
[11] 赵春雷. 盐酸氮卓斯汀鼻喷剂联合地氯雷他定治疗过敏性鼻炎的疗效分析[J]. 河南医学研究, 2015, 24(9):96-97.
[12] 葛佳博. 氮卓斯汀鼻喷剂联合地氯雷他定治疗过敏性鼻炎的效果分析[J]. 当代医学, 2016, 22(16):132-133.
[13] 韩梅. 氮卓斯汀鼻喷剂联合地氯雷他定治疗过敏性鼻炎的临床疗效[J]. 临床医学研究与实践, 2016, 1(27):49-50.
[14] 温俊生. 氮卓斯汀鼻喷剂联合地氯雷他定治疗过敏性鼻炎[J]. 中国城乡企业卫生, 2016, 30(12):90-91.
[15] 吴晓峰, 赵建红. 盐酸氮卓斯汀鼻喷剂与地氯雷他定联合治疗过敏性鼻炎的疗效观察[J]. 中国医院用药评价与分析, 2016, 16(11):1520-1522.
[16] 马德鸿, 倪雪慧. 氮卓斯汀鼻喷剂联合地氯雷他定治疗过敏性鼻炎的临床观察[J]. 世界临床医学, 2016, 10(6):98-101
[17] 冯淬阳. 过敏性鼻炎40例氮卓斯汀鼻喷剂联合地氯雷他定治疗的效果评价[J]. 医药前沿, 2017, 7(4):118-119.
[18] 陈健. 盐酸氮卓斯汀鼻喷剂联合地氯雷他定治疗过敏性鼻炎的疗效观察[J].临床医学研究与实践, 2017, 2(20):23-24.
[19] 赵延明, 张罗. 过敏性鼻炎的遗传学研究进展[J]. 首都医科大学学报, 2013, 34(6):808-813..
[20] 付艳乔, 李国义. 特异性免疫治疗与糖皮质激素对变异性鼻炎患者Th17和RORγt的影响[J]. 解放军医药杂志, 2016, 28(12):109-112.
[21] Klimek L, Demoly P, Price D. Effectiveness of allergic rhinitis treatments in real-life with a focus on MP-AzeFlu.[J]. Expert Rev Clin Pharmacol, 2016, 9(5):705-714.
[22] 冯江, 李艺梅, 韦明,等. 丙酸氟替卡松鼻喷剂联合电针治疗常年性变应性鼻炎效果观察[J]. 临床误诊误治, 2017, 30(11):101-105.
[23] Horak F, Zieglmayer U P, Zieglmayer R, et al. Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis:a pharmacodynamic study of onset of action and efficacy.[J]. Curr Med Res Opin, 2006, 22(1):151-157.
[24] 饶兴旺, 陈琴娟, 陈晓云,等. 盐酸氮卓斯汀喷剂联合地氯雷他定对变应性鼻炎患者炎症因子、细胞功能和IgE水平的影响[J]. 中国生化药物杂志, 2016, 36(9):42-44.